Clinical Trial

Comparison of the Effect of Carbetocin Versus Oxytocin in the Prevention of Postpartum Hemorrhage After Emergency Caesarean Section in Antenatal Low-risk Patients

Study acronym: EMERGE-CS
Completed
View on ClinicalTrials.gov →
Summary
This study will be conducted to compare the effects of pabal and oxytocin administered to prevent postpartum hemorrhage in patients who were followed in the delivery room due to vaginal labor but underwent cesarean section due to emergency situations.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-24.
Trial Details
NCT Number NCT07380529
Lead Sponsor Ankara Etlik City Hospital
Conditions Postpartum Hemorrhage \(PPH\)
Enrollment 300 participants
Start Date 2024-10-01
Primary Completion 2025-08-04 (estimated)
Study Completion 2025-08-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-13